Recombinant bovine coronavirus E2 and E3 polypeptides and vaccines
US5672350A · kind A · utility
7Cited by
8References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 22, 1993 |
| Grant date | Sep 30, 1997 |
| Priority date | — |
| Expiry date | Dec 22, 2013 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2770/20022
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Nucleic acid sequences encoding the Bovine Coronavirus E2 (or BCV S) and E3 (or BCV HE) structural glycoproteins and methods of producing these proteins, including recombinant expression, e.g., in mammalian or insect cells, are provided. The E2 and E3 proteins or antigenic fragments thereof are useful components for Bovine Coronavirus vaccines and methods of treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.